Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ERCC2 positive + SYP negative + EGFR exon 21 mutation
i
Other names:
ERCC2, EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD, Excision repair cross-complementation group 2, SYP, Synaptophysin, Major Synaptic Vesicle Protein P38, MRXSYP, MRX96, syp, EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1956
;
2068
;
6855
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
EGFR exon 19 deletion (79)
EGFR amplification (52)
EGFR exon 18 deletion (3)
EGFR exon 2-7 deletion + EGFR amplification (2)
EGFR amplification + ERBB2 amplification (1)
EGFR exon 19 deletion + HER-2 amplification (1)
EGFR exon 21 deletion (1)
EGFR T790M + exon 19 deletion (0)
EGFR amplifcation (0)
EGFR exon 19 deletion (79)
EGFR amplification (52)
EGFR exon 18 deletion (3)
EGFR exon 2-7 deletion + EGFR amplification (2)
EGFR amplification + ERBB2 amplification (1)
EGFR exon 19 deletion + HER-2 amplification (1)
EGFR exon 21 deletion (1)
EGFR T790M + exon 19 deletion (0)
EGFR amplifcation (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ERCC2 positive + SYP negative + EGFR exon 21 mutation
Lung Adenocarcinoma
ERCC2 positive + SYP negative + EGFR exon 21 mutation
Lung Adenocarcinoma
erlotinib
Sensitive: C4 – Case Studies
erlotinib
Sensitive
:
C4
erlotinib
Sensitive: C4 – Case Studies
erlotinib
Sensitive
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.